Centessa Pharmaceuticals plc

NASDAQ:CNTA

11.92 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000006.913000000000000000
Cost of Revenue 00.22800.2360.240.2480.2370.2380.090.0360.0350.0320.0280.0120.01300.0020000
Gross Profit 000-0.236-0.246.664-0.237-0.238-0.09-0.036-0.035-0.032-0.028-0.012-0.0130-0.0020000
Gross Profit Ratio 000000.964000000000000000
Reseach & Development Expenses 33.44360.88733.90332.81522.63929.97528.1933.67332.82627.83536.74453.65136.85341.53425.8518.13410.7790.9942.5741.8713.333
General & Administrative Expenses 12.33413.70612.50211.16513.43812.31512.01913.34616.05113.76812.28414.76314.38512.98812.46411.8415.7160.3080.1930.2580.383
Selling & Marketing Expenses 0000-0.248-0.14100000000002.5230000
SG&A 12.33413.70612.50211.16513.1912.17412.01913.34616.05113.76812.28414.76314.38512.98812.46411.8418.2390.3080.1930.2580.383
Other Expenses 0000-1.537-0.878-1.677-1.527-1.346-0.07-3.1435.3590.1960.235-1.906-0.19100000
Operating Expenses 45.77774.5846.40543.9835.8342.14840.20947.01948.87741.60349.02868.41451.23854.52238.31429.97519.0193.1842.0382.1392.925
Operating Income -30.777-74.58-46.405-43.98-36.069-35.484-40.209-47.019-48.877-41.603-49.028-68.414-53.218-58.292-38.314-41.287-19.021-3.005-2.116-2.129-3.192
Operating Income Ratio 00000-5.133000000000000000
Total Other Income Expenses Net 6.039-35.74.4470.869-1.475-0.515-1.265-1.918-1.16-2.234-4.9883.731-1.2-2.368-1.841-0.164-221.267-0.281-0.022-0.0990.181
Income Before Tax -24.738-110.279-41.958-43.111-37.544-36.003-41.474-48.937-50.037-43.837-54.016-64.683-54.418-60.66-40.155-41.451-240.288-3.286-2.138-2.228-3.011
Income Before Tax Ratio 00000-5.208000000000000000
Income Tax Expense 1.3971.050.6080.7050.4811.154-2.826-24.0510.677-0.664-0.141-0.0220.080.114-0.065-11.33900-0.022-0.0990.181
Net Income -26.135-111.351-42.566-43.816-38.024-37.157-38.648-24.886-50.714-43.173-53.875-64.661-54.498-60.774-40.155-41.451-240.288-3.286-2.138-2.228-3.011
Net Income Ratio 00000-5.375000000000000000
EPS -0.2-0.84-0.37-0.4-0.38-0.38-0.4-0.26-0.53-0.46-0.57-0.69-0.6-0.68-0.45-0.65-2.75-0.22-0.01500
EPS Diluted -0.2-0.84-0.37-0.4-0.38-0.38-0.4-0.26-0.53-0.46-0.57-0.69-0.6-0.68-0.45-0.65-2.75-0.22-0.01500
EBITDA -30.777-106.573-39.165-40.395-34.776-33.163-38.47-46.399-48.035-41.949-51.692-62.475-52.691-58.212-39.962-41.287-240.237-3.004-0.022-0.0990.181
EBITDA Ratio 00000-4.797000000000000000